Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential effects. Early findings suggest that this higher dosage may boost the drug's ability to control blood sugar, potentially offering more significant outcomes for individuals with type 2 diabetes. Further study is underway to fully explore the long-term